ATE317016T1 - Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten - Google Patents

Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten

Info

Publication number
ATE317016T1
ATE317016T1 AT01994211T AT01994211T ATE317016T1 AT E317016 T1 ATE317016 T1 AT E317016T1 AT 01994211 T AT01994211 T AT 01994211T AT 01994211 T AT01994211 T AT 01994211T AT E317016 T1 ATE317016 T1 AT E317016T1
Authority
AT
Austria
Prior art keywords
genome
production
human cytomegalovirus
chromosomes containing
yeast chromosomes
Prior art date
Application number
AT01994211T
Other languages
English (en)
Inventor
Peter Ghazal
Huang Huang
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE317016T1 publication Critical patent/ATE317016T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/206—Pseudochromosomes, minichrosomosomes of yeast origin, e.g. YAC, 2u
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01994211T 2000-11-03 2001-10-30 Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten ATE317016T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/705,400 US6692954B1 (en) 2000-11-03 2000-11-03 Generation of human cytomegalovirus yeast artificial chromosome recombinants

Publications (1)

Publication Number Publication Date
ATE317016T1 true ATE317016T1 (de) 2006-02-15

Family

ID=24833288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01994211T ATE317016T1 (de) 2000-11-03 2001-10-30 Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten

Country Status (8)

Country Link
US (1) US6692954B1 (de)
EP (1) EP1356062B1 (de)
AT (1) ATE317016T1 (de)
AU (1) AU2002246634A1 (de)
DE (1) DE60117053T2 (de)
DK (1) DK1356062T3 (de)
ES (1) ES2255583T3 (de)
WO (1) WO2002057437A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790867B2 (en) * 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
WO2005052159A1 (en) 2003-11-28 2005-06-09 The University Of Sydney Latent phase viral interleukin-10-(vii-10) and uses thereof
US8088902B2 (en) * 2004-04-05 2012-01-03 The Rockefeller University DNA virus microRNA and methods for inhibiting same
NZ554824A (en) 2004-10-22 2010-10-29 Revivicor Inc Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
US9267132B2 (en) 2007-10-08 2016-02-23 Synthetic Genomics, Inc. Methods for cloning and manipulating genomes
DK2348827T3 (en) 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS
CA2754212C (en) 2009-03-06 2016-08-02 Synthetic Genomics, Inc. Methods for cloning and manipulating genomes
WO2011109031A1 (en) 2010-03-05 2011-09-09 Synthetic Genomics, Inc. Methods for cloning and manipulating genomes
CA2882661C (en) 2012-08-31 2018-12-11 Synthetic Genomics, Inc. Crowding agent-induced nucleic acid transfer into a recipient host cell
US20150307850A1 (en) * 2012-12-04 2015-10-29 Merck Sharp & Dohme Corp. Conditional replicating viral vectors
WO2015047901A1 (en) * 2013-09-24 2015-04-02 Duke University Compositions, methods and kits for eliciting an immune response
WO2016168741A2 (en) * 2015-04-16 2016-10-20 Spencer Juliet V Detection of human cytomegalovirus
US20200182884A1 (en) 2016-06-27 2020-06-11 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
US5552143A (en) 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5591439A (en) 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
WO1995003400A1 (en) 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
US5721354A (en) 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences
DE19733364A1 (de) 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Verfahren zur Klonierung eines großen Virusgenoms
US6277621B1 (en) 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences

Also Published As

Publication number Publication date
DK1356062T3 (da) 2006-05-15
HK1055762A1 (en) 2004-01-21
EP1356062B1 (de) 2006-02-01
US6692954B1 (en) 2004-02-17
ES2255583T3 (es) 2006-07-01
AU2002246634A1 (en) 2002-07-30
WO2002057437A3 (en) 2003-08-14
WO2002057437A2 (en) 2002-07-25
DE60117053D1 (de) 2006-04-13
EP1356062A2 (de) 2003-10-29
DE60117053T2 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
DE60117053D1 (de) Herstellung rekombinanter künstlicher hefe-chromosome, welche das genom des humanen cytomegalovirus enthalten
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
EP2336370A3 (de) Rekombinante Newcastle-Disease-Virus RNA Expressionssysteme und Impfstoffe
EA200401506A1 (ru) Рекомбинантный поксвирус, экспрессирующий гомологичные гены, встроенные в поксвирусный геном
PT1212358E (pt) Genes sinteticos de papilomavirus humano
DE69836206D1 (de) Synthetische hiv gag gene
NO874750D0 (no) Bestemte dna-sekvenser avledet fra en papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
YU37502A (sh) Infektivni klonovi
EP0400958A3 (de) Lebende Impfstoffe
ATE369428T1 (de) Behandlung von gebärmutterhalskrebs
EA200500879A1 (ru) Рекомбинантный поксвирус, содержащий по меньшей мере два промотора ati коровьей оспы
DE60238309D1 (de) Tomegalovirus genom mit konserviertem wildtyp-charakteristika klinisher isolate enthält
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
UA90098C2 (en) Promoter of vaccinia virus
WO2000053776A3 (en) Human kallikrein-like genes
NO20013102D0 (no) Gener, proteiner og deres anvendelse
IL164179A0 (en) Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
DK1235916T3 (da) Isolerede polynukleotider med et formindsket indhold af 5'CpG3' epigenitiske kontrolmotiver og anvendelser deraf
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
HUP0200320A2 (hu) Macskaeredetű CD28-at, CD80-at, CD86-ot vagy CTL4-A-t expresszáló rekombináns vírusok és alkalmazásuk
EP0884382A3 (de) Verfahren zur Herstellung von Marek's Krankheitsvirus unter Verwendung von Säugetier-Zellinien
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
SE0002498D0 (sv) Papillomavirus vaccine
WO2002097081A3 (en) Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties